Telix Pharmaceuticals 与 QDOSE 和 ABX-CRO 合作,将 QDOSE 剂量测定软件集成到治疗放射性药物项目中。 Telix Pharmaceuticals partners with QDOSE and ABX-CRO to integrate QDOSE dosimetry software into therapeutic radiopharmaceutical programs.
Telix Pharmaceuticals 与 QDOSE 和 ABX-CRO 合作,将 QDOSE 剂量测定软件平台商业集成到治疗性放射性药物项目中。 Telix Pharmaceuticals partners with QDOSE and ABX-CRO to commercially integrate the QDOSE dosimetry software platform into therapeutic radiopharmaceutical programs. QDOSE 是一个多功能软件平台,可以可靠地估计治疗和诊断放射性药物的患者特异性剂量测定。 QDOSE is a versatile software platform that allows for reliable estimation of patient-specific dosimetry for both therapeutic and diagnostic radiopharmaceuticals. 此次合作旨在开发个性化治疗方案,优化治疗反应,同时最大限度地减少对健康器官的影响并简化同位素供应链。 This collaboration aims to develop personalised treatment regimens, optimizing treatment response while minimizing effects on healthy organs and streamlining isotope supply chains.